We also demonstrated that treatment with rGDF11 from 7 days after stroke significantly enhanced neurogenesis and angiogenesis and improved functional outcome through regulating the TGF-β/Smad2/3 signaling pathway. This evidence concerns the gene TGFB1 and stroke disorder.